Azacitidine accord 25mg
Description: An anti-cancer agent (chemotherapy) belonging to the group of medicines called “anti-metabolites” (pyrimidine analogues). It is a white lyophilised powder or cake that, when reconstituted, forms a suspension for injection.
Share Now
Additional Information
Product Name: Azacitidine Accord 25 mg/mL powder
Active Ingredient: Azacitidine.
Description: An anti-cancer agent (chemotherapy) belonging to the group of medicines called “anti-metabolites” (pyrimidine analogues). It is a white lyophilised powder or cake that, when reconstituted, forms a suspension for injection.
Indication: Used to treat adults who are not eligible for stem cell transplantation with:
- Intermediate-2 and high-risk myelodysplastic syndromes (MDS).
- Chronic myelomonocytic leukaemia (CMML).
- Acute myeloid leukaemia (AML).
Strength: 100 mg per vial. (After reconstitution with 4 mL of water, the suspension contains 25 mg/mL of azacitidine)
Business Partner: Accord Healthcare
Related Products
Related products
Disclaimer
Pharma Solutions is the master distributor for the listed products in Egypt. The products are either registered and approved by the respective local health authority or contracted by the MAH to supply to the end users on a named patient basis. Some products such as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.




